Tuesday , October 24 2017
Home / Resources / Polls (page 11)


Novo’s Two New Insulins


Last Friday, the FDA -- after rejecting them once -- finally approved Novo's two new Insulins, Tresiba and Ryzodeg. (See article for details.) Do you feel comfortable in recommending either to your patients? Follow the link to respond.

Read More »